Interactions between vascular endothelial cells (ECs) and biomaterials are important for engineered tissue substitute. The modification of biomaterial surfaces are designed to modulate EC adhesion and responses in order to improve implantation success rate. Specifically, it has now been well established that increased vascular tissue regeneration can be achieved on almost any surface by employing novel nanofabricated surface features. To enhance EC adhesion and growth, material surfaces have been modified with physicochemical and mechanical properties, such as bioactive molecules from the matrix, peptides, and/or growth factors to control EC behavior. The advances in nanotechnology can bring additional functionality to vascular tissue engineering, optimize internal vascular graft surface, help to direct the differentiation of stem cells into the vascular cell phenotype, and, most importantly, also provide a biomaterials-based cellularization process. Nanomaterials could promote in situ endothelialization by mobilizing endothelial progenitor cells (EPCs) from the bone marrow, by encouraging cell-specific adhesion to the vascular graft, and, once attached, by controlling the proliferation and differentiation of these cells. Interaction between different cell types and extracellular matrix continue to be a principal source of inspiration for material biological function and, therefore, the understanding of the molecular mechanism trigger by the interaction is discussed.
INTRODUCTION
hibiting thrombosis and formation of blood clots (5) . There is plenty of evidence showing that development of nanotechnology-based methods in vascular tissue bio-Synthetic materials used in vascular conduits applications have been indicated to be prone to clot and fail, fabrication represents one of the most important technological breakthroughs in vascular tissue engineering. and do not function well in the long term. The urgent need in the clinic has driven the search for a better and Nanostructuralized scaffolding can mimic the organization of a natural vascular extracellular matrix (ECM) more biologically compatible blood vessel replacement. Numerous approaches have been used to fabricate the and thus improve cell adhesion ability (38) . Several observations indicated that biomaterials seeded with differ-structure and the function of blood vessels (20, 38, 50) . The vascular tissue engineering approach is to use a entiated endothelial cells (ECs) (15, 29) or ECs in combination with other cell types such as smooth muscle cells good biocompatibility material that is seeded with cells. The advance in nanotechnology brings additional func-(SMCs) (56) promoted vascular tissue repair after artificial graft implantation. In order to improve the tech-tionality to vascular conduits; it optimizes internal vascular graft surface and even helps to direct the differenti-nology in vascular grafts, we need the knowledge and expertise in tissue engineering. Regarding previous find-ation of stem cells into the vascular phenotype (1, 26) . Nanotechnology also offers the key to understand the ings, nanotechnology approaches seemed to exhibit an important role in the endothelialization processing, in-surface properties of materials on devices such as valves and stents. That promisingly improves biocompatibility cluding endothelial cell migration, adhesion, proliferation, and differentiation. Therefore, this article reviews of the device by regulating cell adhesion ability and in-nanobiomaterials in vascular tissue engineering, which medical devices with nanoscale features of smooth muscle cells (SMC) (56) . It has been suggested that synthetic provide a mimic condition of the vascular tissue suitable for endothelial cell adhesion.
aligned poly(L-lactid-co-epsilon-caprolactone) [P(LLA-CL)] copolymer combines with the advantages of syn-NANOSCALE TOPOGRAPHY thetic biodegradable polymers may represent an ideal AND VASCULAR TISSUE tissue engineering scaffold, especially for blood vessel engineering (55) . Recently, synthetic poly-L-lactic acid It is of interest to note that nanostructuralized biomaterials can modify the organization of a natural vascular (PLLA) nanofibers have been shown to not only improve biocompatibility with outgrowth endothelial cells ECM and thus improve cell attachment (2). One explanation is provided by the evidence that nanostructured (OEC) but also promote and guide aligned OEC sustained proliferation (31). Based on these findings, the surface features can significantly improve vascular cell proliferation; such design criteria can be used in the syn-aligned PLLA, which can serve as the scaffold and promote cell growth during endothelialization of biomateri-thesis of the more successful tissue-engineered vascular grafts (37) . For example, hydrogels have been modified als, can provide a promising way to prevent intimal hyperplasia of small-diameter vascular grafts. with growth factors and ECM peptides on nanostructure biomaterials, which brought additional functionalities Engineered vascular grafts with polyhedral oligomeric silsesquioxane modified polycarbonate urea-ure-and improved the capacity of the hydrogel to direct cell differentiation and tissue regeneration (5, 42) . Indeed, thane (POSS-PCU), which was cross-linked with a bioactive RGD peptide and formed a biofunctionalized surface-aminated electrospun nanofibers that enhance adhesion and expansion of human umbilical cord blood nanocomposite polymer-based small diameter bypass graft, has been shown to have the potential for rapid hematopoietic stem progenitor cells have been observed (8) . Additionally, a study also showed that ECs, when endothelialization (12) . A similar approach using poly (carbonate) urethane-based nanocomposite polymer in-cultured on gelatin-grafted electrospun poly(caprolactone) (PCL) nanofiber, were able to maintain the expres-corporating polyhedral oligomeric silsesquioxane (POSS) nanocages (UCL-NANO) showed antithrombogenicity sion of three characteristic markers: platelet-endothelial cell adhesion molecule 1 (PECAM-1), intercellular ad-and biostability as well as exhibited a good small caliber quadruple lamina vascular bypass graft method (46). hesion molecule 1 (ICAM-1), and vascular cell adhesion molecule 1 (VCAM-1) (33) . The nanobionic surface
The key materials of vascular tissue engineering are listed in Table 1 . modified small intestinal submucosa (SIS) film possesses good and persistent antithrombogenicity, and also MOLECULAR AND CELLULAR INTERACTION exhibits excellent blood compatibility (17) . Experiment BETWEEN NANOBIOMATERIALS AND was also performed to show that the collagen-blended VASCULAR MICROENVIRONMENT poly(L-lactic acid)-co-poly(epsilon-caprolactone) nanofibers [P(LLA-CL) NFM] could enhance the viability, Nanomaterials are known to be important in vascular tissue application. However, how the molecular signal-spreading, and attachment of ECs, and, moreover, preserve the EC phenotype. The P(LLA-CL) NFM is a po-ing and its biological function is controlled are still unclear. It is extremely important to note that developing tential material for tissue-engineered vascular graft (19) . Indeed, the polyhedral oligomeric silsesquioxane attached such biomaterials requires the modification of materials that mimic molecular mechanism of extracellular matri-by direct reaction onto a urethane segment (UCL-Nano) has been demonstrated to have similar viscoelastic prop-ces (18, 20) . These associated signal molecules could promote vascularization by the mobilization of ECs, in-erties to the walls of a natural artery, which is resistant to degradation and is able to sustain endothelial cell duction of cell-specific adhesion to the vascular graft, and, once attached, by controlling the proliferation and seeding (42) . For example, endothelial progenitor cells respond to ridge-groove grating of 1200 nm in period differentiation of these cells. The benefit from the nanobiomaterials is considered as the advantageous char-and 600 nm in depth on nanotopography substrate with promoted alignment and elongation, reduced prolifera-acteristics of the natural extracellular matrix for tissue repair processing (55) . It is likely that cells adhering to tion, and enhanced migration (4) .
Cells are known to be surrounded by nanoscale to-the ECM induce intracellular signaling cascades and migration of integrins into focal adhesion complexes (21). pography in their natural extracellular environment. It was observed that this surface comprises nanopatterned For example, evidence indicated that manufactured aluminum oxide nanoparticles decrease the expression of gratings with poly(methyl methacrylate) (PMMA) and PDMS can provide a valuable platform for the study of tight junction proteins in brain vasculature (6) . Indeed, cupper-nanoparticles are highly useful for regenerating cell-substrate interactions and for the development of of elastin matrices by adult vascular smooth muscle cells proach also indicated that nanofibrous materials made from bioabsorbable and biocompatible polymers have (SMCs). These results have immense utility in tissue engineering vascular replacements (27). There was further promising applications as tissue-engineered scaffolds. Genetic analysis of human umbilical vein endothelial evidence suggesting that nanostructured hydroxyapatite (HA) crystals upregulate fibroblast growth factor-2 cells (HUVEC) that attached to poly(glycolide) (PGA) nanofibrous materials prepared via electrospinning (FGF-2) expression and activity in microvascular endothelium, promoting angiogenesis in 3D matrices (41) .
methods exhibited high expression of integrin v and VEGF receptor genes, which are known angiogenesis Current issues in nanotechnology and molecular selfassembly may provide novel solutions to cell transplan-markers (24) . The molecular and cellular interaction between nanobiomaterials and the vascular environment is tation deficiencies. An observation has shown that the delivery of vascular endothelial growth factor (VEGF) shown in Table 2 . It is also of interest to note that in conjunction with and FGF-2 from heparin-binding peptide amphiphiles (HBPAs) scaffolds significantly increases blood vessel microvascular dysfunction, nanoparticle exposure also reduces nitric oxide (NO) activation through at least two density in the mouse omentum over control scaffolds without growth factors and significantly promotes islet functional distinct mechanisms that may mutually increase local reactive species (39). A report also bring engraftment (49). The in vitro study demonstrated that cell adhesive proteins adsorbed (vitronectin and fibro-the attention that PU-Au nanocomposites activate FAK and PI3K/Akt signaling pathway in ECs, which leads to nectin) in different quantities and altered bioactivity on nanostructures, which, at least in part, may account for proliferation and migration of ECs on a series of nanocomposites from polyurethane (PU) incorporated with the documented increased vascular cell adhesion on nanostructured PLGA (36) .
various gold nanoparticles (23). Another report also suggested that the nanometric micelles on PU surface may A study from neovascuature has shown that nanosphere-aided targeting of the neovasculature with mutant interact with ECs and accelerate their migration by increasing cytoplasmic Ca 2+ and stimulating the PI3K/Akt/ Raf-1 causes regression of tumor progression (52). Based on this finding, it seems reasonable to conclude eNOS signaling pathway (22) . Indeed, carbon nanoparticles and microparticles have the ability to induce plate-that the nanoparticles coated with specific biological molecules may be useful for delivering signal mole-let activation and enhance vascular thrombosis, and this observation will be important for the pharmacological cules, which can cause the regression of tumor progression. The use of viscoelastic nanocomposites vascular application (43) . These reports lead to the conclusion that biomaterials can successfully integrate into a tis-conduit by exposing to shear stress preconditioning prior to physiological flow can increase endothelial growth sue's mechanical properties and material topography. The cellular molecular mechanism to a biomaterial may factor receptor-2 (VEGFR-2) and transforming growth factor-β1 (TGF-β1) on ECs (51) . Indeed, another ap-be enhanced in synthetic vascular conduits by mimick- PLGA, poly(lactic-co-glycolic acid); VEGF-R2, vascular endothelial growth factor-receptor 2; TGF-β, transforming growth factor-β; FAK, focal adhesion kinase; PI3K/Akt, phosphatidylinositol 3-kinase (PI3K)/Akt; Ca 2+ , calcium.
ing the surface roughness that is created by the associ-spreading, and formation of a confluent endothelial monolayer by circulated progenitor cells (1). ated nanostructured extracellular matrix components of natural tissue (37) . The proposed mechanism by which APPLICATION OF NANOPARTICLES nanomaterials contribute to the modulation nof vascular FOR TRACKING STEM CELLS tissue engineering is shown in Figure 1 .
Many applications of new cellular magnetic labeling PERSPECTIVE ON NANOTECHNOLOGY IN method to EPCs exhibited therapeutic potential for re-MANIPULATING VASCULAR STEM CELLS vascularization. One report indicated that when magnetic nanoparticle-incorporated EPCs were injected into Although stem cells hold great potential for the vascular tissue engineering application, the development of a microfluidic channel by using a syringe pump it can control the flow rate of cells (25) . Magnetic cell delivery advanced and novel method to track and guide transplanted stem cells should be addressed in more detail and targeting offers a new opportunity for vascular tissue engineering and delivery of localized cell-based (48) . For example, nanopatterns on the surface of a vascular graft with nanofilms can increase its adhesion for therapies. Using a magnetically tagged device at a site of artery injury is able to enhance EPC localization (28) . circulating endothelial progenitor cells (12) . Another way to influence stem cell differentiation and transplan-This technology could be more adapted to trace cells in other organs and may provide a novel approach for the tation is engineered nanometer-scale scaffolds (14) . For instance, functional nanofiber scaffolds with different systemic injection of cell therapies in vascular tissue engineering application. When EPCs are labeled with mo-spacers modulate adhesion and expansion of cryopreserved umbilical cord blood hematopoietic stem/progen-nocrystalline iron oxide nanoparticles (MIONs), it does not adversely change their viability and its migration itor cells (7) . This is especially noteworthy in the case of scaffold topography and cell-substrate interaction that ability in vitro, and this allowed successful detection of limited numbers of these cells in muscle (30) . MION-regulate hematopoietic stem and progenitor cell (HSPC) proliferation and self-renewal in cytokine-supplemented labeled EPCs provides a noninvasive strategy to monitor the location of small signal molecules of these cells. expansion.
The formation of an endothelial cell layer on the lu-There is a technique using advanced ultra-high-field 7-Tesla (7T) MRI of nanoparticle-labeled transplanted minal surface of vascular grafts is an important attribute to improve their potential for endothelialization. The human EPCs in porcine ischemic hearts for clinical application (45). Indeed, another report also pointed out formation of blood vessels is mainly due to the activity of EPCs (3) . It is of interest to note that nanocomposite-that magnetically labeled EPCs transplanted for therapeutic neovascularization in myocardial ischemia can be containing bioactive peptides could promote adhesion, visualized by MRI (54) . It has been observed that self-nology can be extended by using additional agents aimed to target multiple signaling pathways, such as hy-synthesized superparamagnetic iron oxide particles (PLL-SPIO) can effectively improve EPC mobilization and poxia-inducible factor-1α (HIF-1α), as well as a temporal targeting of tumor cells (47) . It was observed in a proliferation (34). Therefore, it can be assumed that PLL-SPIO can serve as a tracker for implanted EPCs.
NOD/SCID mouse hind limb vascular injury model that nanofiber-expanded cells exhibited more therapeutic po-NANOBIOMATERIALS FOR THE DELIVERY tential in blood flow restoration after further applying OF VASCULAR GENETIC MOLECULES VEGF ( 16), PDGF-BB, and growth factor (11) . Additionally, overexpression of proangiogenic growth factor Strategies for vascular conduit application have been focused on the delivery of angiogenic growth factors can promote the cellular therapeutic efficiency in EPCs for ischemic disease (58) . In summary, nanofiber-based such as VEGF and FGF-2 to induce angiogenesis progress from the host vasculature (32, 35) . Nanofibrous ex vivo expansion technology can provide a novel therapeutic strategy for stem cells in vascular tissue engineer-materials made from bioabsorbable and biocompatible polymers are promising applications as tissue-engi-ing. Moreover, the immobilization of CD34 antibodies on a lumenal vascular stent enhanced recruitment of cir-neered scaffolds (9) . The nanocell comprising a nuclear nanoparticle within an extranuclear pegylated-lipid en-culated cells and accelerated postimplantation endothelialization in vitro (44) . velope is preferentially taken up by the tumor. The tech- Figure 1 . Schematic representation of the proposed mechanism by which nanomaterials contribute to the modulation of vascular tissue engineering. As a result of vascular tissue injuring, the nanomaterials (including nanoparticles, nanofibers, nanocarries, nanostructure pattern, nanosphere, and nanofluore) trigger molecular mechanism by virtue of their expression of tight junction protein, adhesion molecules (e.g., FAK, integrin V), signaling molecules (e.g., PI3K/Akt, eNOS, and Ca 2+ ), growth factors (e.g., FGF-2, VEGF-R2, and TGF-β), and extracellular matrix (e.g., elastin, fibronectin, and vitronectin). The interaction of endothelial cells with injured tissue could lead to activation of signal molecules that may contribute to the recovery of vascular injury (e.g., increase the adhesion, migration, proliferation, angiogenesis), promotion of drug delivery (e.g., regulatory of cancer), and tracing of stem cell differentiation. These molecular effects of nanomaterials contribute to restored vascular tissue regeneration of the injured area and result in the induction of endothelialization.
FUTURE PROSPECTS
understanding of hematopoietic stem cell biology and property. The incorporation of vascular tissue engineering, CONCLUSION stem cell application, and nanotechnology research can Nanotechnology has become an attractive method for improve regenerative medicine for current clinical applivascular tissue engineering from the viewpoint of biolcation. Recently, the application of stem cells to vascuogy (i.e., stem cells, extracellular matrix, growth factors, lar tissue engineering has become a novel technology. and signaling molecules). A range of nanobiomaterials Having developed a fully biological vascular graft, funchas been shown to provide an excellent biocompatibility tional concerns about its biological compatibility and for many processes that occur in the early stages of vesmechanical property have become the focus of research sel repair and allow a long-term maintenance of neoeffort. Although the main goal of nanotechnology is to vascular tissue development. The endothelialization of enhance the ability to repair vascular tissue, it is unclear synthetic nanobiomaterials is a promising therapeutic how nanobiomaterials mimic the native properties of approach to create a nonthrombogenic barrier on surblood vessel grafts in a long-term implantation in vivo faces, and could thereby improve the efficiency of vasand this will be the important issue to be further pursued cular prosthesis of blood contacting devices. The design for a new therapy strategy. For example, development of athrombogenic nanosurfaces on vascular grafts and of genetic engineering methods (47, 52) and the variety the development of nanopatterned biomimicking vascuof cell types that are able to express signaling molecules lar grafts are already well established. The use of nano-(6,22,23,39), proteins (27,36), peptides (49), and growth patterned functionalized biomaterials for the expansion factors (13, 32, 35, 58) all show great promise for modifiand directed differentiation of human stem cells into cation of vascular nanobiomaterials. However, a more cells of vascular lineage is a fast evolving and promising advanced knowledge on the modulation of molecular technology. The development of novel methods of vasmechanism will provide a medium closely mimicking cular tissue assembly and rapid vascular biofabrication, the physiological environment within an engineered vassuch as magnetic force-driven tissue engineering and sicular graft. This may advance a better biocompatibility, multaneous electrospinning of vascular scaffolds and ultimately providing more durable vascular nanobiomatliving cells, represents probably the most important erials. Alternatively, advanced nanobiomaterial fabricabreakthroughs to date. tion and application will be essential for more functional Based on the above findings, evidence strongly indivascular tissue in regenerative medicine. For example, cates the potential of nanotechnology in vascular tissue modification of nanobiomaterials has been shown to engineering for the development of successful and effechave a lower degradation rate in vivo, and this promotes tive vascular tissue-engineered products. Immobilization the host immune response (57) . A concern remains reof homing factor mimetic molecules onto synthetic nagarding the trace amounts of potentially antigenic comnobiomaterials to increase the production of EPCs from pounds of animal origin (lipids, DNA, glycosilation circulating blood opens a new therapeutic strategy in reproducts) that have been reported to be present in varigenerative medicine. This concept is based on the underous types of nanobiomaterial and may induce an inflamstanding that every patient will be able to seed his immatory response at the implantation site (10, 16) .
plants with his own progenitor cells after implantation, A recent study has demonstrated that the tissueand this technology may bring new therapeutic strategy specific matrix components cause significant different for vascular tissue engineering. adhesion efficiency and phenotype (31,40) of vascular For reasons mentioned above, the application of sigtissue, as well as endothelial cells. These observations nal molecules can be incorporated into functional develsuggest the need for more appropriate, tissue-specific opment of nanobiomaterials for regulation of stem cell nanobiomaterials from in vitro to in vivo study. Indeed, mobilization of vascular biology. With the incorporation utilization of nanobiomaterials in clinical application of nanotechnology, biomaterial surface modification and may provide successful vascular tissue regeneration for stem cell biology for developing a novel therapeutic the patient. It is worthy of consideration that circulating strategy could be advanced for vascular tissue engihematopoietic blood stem cells from bone marrow (53), neering. umbilical cord blood (7) , or peripheral blood (12) have a high proliferative and regenerative potential, and they REFERENCES may be an optimal and ideal cell source for mimicking
